TheraNova has created and spun-out a number of venture capital funded companies, including:


TheraNova’s spin-outs are backed by well-known institutional and strategic investors, including: Boston Scientific, Allergan, Highland Capital, Onset Ventures, Sante, Scientific Health Development, Oakwood, Easton Capital, Third Point Ventures, WS Investment Co. and others. Additional information on the investment activity of our spin-outs is made available to the public via the SEC website and at


Theranova’s portfolio of incubated companies is supported by a mix of internal capital, grant and angel funding.

For more information on our incubated programs or to learn about upcoming investment opportunities, please email us at

CompanyTechnologyDevelopment StatusFinancing
RespirixNon-invasive alternative to CardioMems for Congestive Heart FailureCompleted Initial In Vivo StudiesVC Seed Funded
PerikineticsIntraperitoneal Artificial Pancreas for Type 1 DiabetesInitial feasibility studyNIH & Private grants
GravitasEnteral Feeding & Monitoring technologyCompleted Initial In Vivo StudiesInternal funding
Empower NeurosciencesNon-invasive neuromodulation for the treatment of substance use disordersPilot clinical studiesNIH grant
Ektos BiomedicalLow-cost gait analysis for early disease detectionPilot clinical studiesInternal funding
SENS DeviceProvides smart and safe entry to the peritoneal cavity in preparation for laparoscopic proceduresInitial feasabilityNIH grant
FlowGen SolutionsMinimally invasive cryotherapy technology for treatment of BPH (benign prostatic hyperplasia)Initial feasibility studiesNIH grant
PulmonO2Automated peritoneal lavage system to supplement lung function during respiratory failureInitial feasibility studyInternally funded